-
Bad Bunny promises to bring Puerto Rican culture to Super Bowl
-
Venezuela amnesty bill excludes gross rights abuses under Chavez, Maduro
-
Lower pollution during Covid boosted methane: study
-
Doping chiefs vow to look into Olympic ski jumping 'penis injection' claims
-
England's Feyi-Waboso in injury scare ahead of Six Nations opener
-
EU defends Spain after Telegram founder criticism
-
Novo Nordisk vows legal action to protect Wegovy pill
-
Swiss rivalry is fun -- until Games start, says Odermatt
-
Canadian snowboarder McMorris eyes slopestyle after crash at Olympics
-
Deadly storm sparks floods in Spain, disrupts Portugal vote
-
Ukrainian flag bearer proud to show his country is still standing
-
Carney scraps Canada EV sales mandate
-
Morocco says evacuated 140,000 people due to severe weather
-
Spurs boss Frank says Romero outburst 'dealt with internally'
-
Giannis suitors make deals as NBA trade deadline nears
-
Carrick stresses significance of Munich air disaster to Man Utd history
-
Record January window for transfers despite drop in spending
-
'Burned inside their houses': Nigerians recount horror of massacre
-
Iran, US prepare for Oman talks after deadly protest crackdown
-
Winter Olympics opening ceremony nears as virus disrupts ice hockey
-
Mining giant Rio Tinto abandons Glencore merger bid
-
Davos forum opens probe into CEO Brende's Epstein links
-
ECB warns of stronger euro impact, holds rates
-
Famine spreading in Sudan's Darfur, warn UN-backed experts
-
Lights back on in eastern Cuba after widespread blackout
-
Russia, US agree to resume military contacts at Ukraine talks
-
Greece aims to cut queues at ancient sites with new portal
-
No time frame to get Palmer in 'perfect' shape - Rosenior
-
Stocks fall as tech valuation fears stoke volatility
-
US Olympic body backs LA28 leadership amid Wasserman scandal
-
Gnabry extends Bayern Munich deal until 2028
-
England captain Stokes suffers facial injury after being hit by ball
-
Italy captain Lamaro amongst trio set for 50th caps against Scotland
-
Piastri plays down McLaren rivalry with champion Norris
-
ECB holds interest rates as strong euro causes jitters
-
Spain, Portugal face floods and chaos after deadly new storm
-
EU close to sealing trade deal with Australia
-
German Cup final to stay in Berlin until 2030
-
What does Iran want from talks with the US?
-
Taming the lion: Olympians take on Bormio's terrifying Stelvio piste
-
Wind turbine maker Vestas sees record revenue in 2025
-
Italy's Casse tops second Olympic downhill training
-
Anti-doping boss 'uncomfortable' with Valieva's coach at Olympics
-
Bitcoin under $70,000 for first time since Trump's election
-
'I am sorry,' embattled UK PM tells Epstein victims
-
England's Brook predicts record 300-plus scores at T20 World Cup
-
Ukraine, Russia swap prisoners, US says 'work remains' to end war
-
Wales' Rees-Zammit at full-back for Six Nations return against England
-
Sad horses and Draco Malfoy: China's unexpected Lunar New Year trends
-
Hong Kong students dissolve pro-democracy group under 'severe' pressure
| SCS | 0.12% | 16.14 | $ | |
| RBGPF | 0.12% | 82.5 | $ | |
| RYCEF | -0.36% | 16.62 | $ | |
| CMSC | -0.04% | 23.51 | $ | |
| NGG | -1.02% | 86.9 | $ | |
| GSK | 3.55% | 59.335 | $ | |
| RIO | -4.93% | 91.945 | $ | |
| CMSD | -0.02% | 23.865 | $ | |
| RELX | 1.19% | 30.14 | $ | |
| BCE | -3.51% | 25.447 | $ | |
| VOD | -7.24% | 14.65 | $ | |
| BTI | 0.8% | 62.13 | $ | |
| BCC | -1.78% | 88.65 | $ | |
| BP | -2.63% | 38.195 | $ | |
| JRI | -0.46% | 13.09 | $ | |
| AZN | 0.33% | 188.08 | $ |
Dogs die as South Africa snake antivenom shortage bites
Zarza, a much-loved Staffordshire terrier, ended up at a South African animal hospital with a bite from a Mozambique spitting cobra on her snout.
The snake's powerful venom can stop the breathing muscles from working, but normally the bites are treatable with an antidote.
The problem, say South African veterinarians, is that they currently have virtually no vials of the antiserum left.
"We've been out of antivenom for quite some months now," said Dean de Kock, a vet at the Valley Farm Animal Hospital in Pretoria, where Zarza was treated but eventually died.
Vets and snake experts say the shortage started getting serious towards the end of last year -- though the authorities are denying there is a problem.
"Snakebite antivenom is available in the country," the National Health Laboratory Service (NHLS), a government body in charge of antidote production, told AFP.
Experts in the field disagree.
- A 'countrywide shortage' -
In April, a group of snakebite treatment specialists pleaded with the health minister over what they described as "a major health risk".
While the supply problems may be easing in some quarters, vets say they are still struggling.
Hospitals treating humans get priority when any new doses come available, said Johan Marais, a herpetologist -- specialist in reptiles and amphibians -- who heads the African Snakebite Institute.
"At the moment, if you're a veterinarian, you cannot get antivenom," said Marais, 65.
Speaking from his headquarters in Pretoria, he casually handled a black mamba during his conversation with AFP.
He said he receives up to a dozen calls a day from desperate animal doctors and dog owners looking for antidotes.
"If your dog gets a serious snakebite today, there's a likelihood it's going to die," Marais said.
Alan Kloeck, of the South African Veterinary Association, confirmed Marais's remarks, describing a "countrywide shortage" with vets unable to get their hands on the antiserum they needed.
- Horse blood, spitting cobras -
South Africa is home to about 160 species of snakes, many of them poisonous.
South African Vaccine Producers -- a NHLS subsidiary and the only antivenom maker in the country -- produces two antidotes.
One can treat bites from 10 snakes including the cape cobra, the puff adder and the green mamba, while another is for relatively rare boomslang bites.
Making the antiserums is a laborious process, said Mike Perry of African Reptiles and Venom, a venom-extraction firm in Centurion, outside Johannesburg, that houses around 900 snakes in small glass cages.
He said his team forces the hissing reptiles to spit out their poison by forcing them to bite a glass jar.
Small quantities of the toxins are then injected into horses, which over time develop immunity.
Their plasma is then harvested and processed to make the serum.
But that process requires constant refrigeration, and the production backlog has been blamed in large part on South Africa's energy crisis, which has caused repeated power blackouts.
In April, NHLS said it required "a consistent and dependable power supply" to produce antivenom.
The continuous switchover to generators during outages interrupted production and affected stockpiles, it said, forcing it to invest in backup power systems and renewable energy.
- 'Last vial' -
Last week, NHLS said it had increased manufacturing in recent months.
Since January, it said, it had delivered antivenom to more than 230 institutions, including hospitals and veterinary clinics, fulfilling all orders apart from "a small backlog" affecting a provincial depot.
But de Kock, whose veterinary practice is in a different province, has not received any shipments since December. For a while, they were using expired doses from other hospitals, but these too have dried up.
"We have used the last vial on Sunday evening," he said last week.
Over the past three months, the hospital treated 25 dogs for snakebites.
Of the 16 who could get expired antivenom, only one did not survive, while six of the nine who could not get doses died.
Zarza was among them, dying in May after a two-day struggle on a ventilator.
"It's tough," said de Kock, 53. "You're doing everything you can but the vital thing that you actually need is the antivenom, and you don't have that".
His hope was that the austral winter months, when snakes are less active, would bring some relief.
J.AbuHassan--SF-PST